Jack Nathan Medical Corp.
JNH.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.29% | -14.61% | 138.64% | 5.69% | -94.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.29% | -14.61% | 138.64% | 5.69% | -94.36% |
| Cost of Revenue | -30.87% | -31.88% | 79.11% | -18.75% | -72.64% |
| Gross Profit | 88.79% | 61.92% | 157.64% | 13.34% | -102.20% |
| SG&A Expenses | -35.75% | -44.49% | 151.11% | 16.48% | -83.76% |
| Depreciation & Amortization | -31.19% | -45.31% | 69.66% | 50.61% | -85.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.94% | -40.48% | 128.32% | 10.63% | -81.44% |
| Operating Income | 40.47% | 47.15% | 27.33% | -37.09% | 22.44% |
| Income Before Tax | 69.89% | 36.63% | -59.71% | 13.04% | 47.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 69.89% | 36.63% | -70.97% | 13.04% | 47.63% |
| Earnings from Discontinued Operations | 181.79% | -1,628.19% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 96.10% | -47.92% | 564.16% | 13.04% | 31.62% |
| EBIT | 40.47% | 47.15% | 27.33% | -37.09% | 22.44% |
| EBITDA | 15.90% | 27.19% | -7.34% | -29.82% | 24.83% |
| EPS Basic | 95.70% | -43.10% | 562.24% | 14.69% | 31.62% |
| Normalized Basic EPS | 70.45% | 39.47% | -15.00% | -23.68% | 25.42% |
| EPS Diluted | 95.74% | -35.21% | 563.27% | 14.69% | 37.33% |
| Normalized Diluted EPS | 69.77% | 39.47% | 0.00% | -19.44% | 24.56% |
| Average Basic Shares Outstanding | 2.79% | 2.79% | 1.83% | 1.88% | 0.00% |
| Average Diluted Shares Outstanding | -0.70% | 2.79% | 2.22% | 7.39% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |